Login / Signup

Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.

Andreas KronbichlerJulia KerschbaumSeerapani GopaluniJoanna TieuFederico AlbericiRachel Bronwen JonesRona M SmithDavid R W Jayne
Published in: Annals of the rheumatic diseases (2018)
We found severe infections in one quarter of patients with AAV receiving rituximab. Trimethoprim-sulfamethoxazole prophylaxis reduced the risk, while especially bronchiectasis and endobronchial involvement are risk factors for severe respiratory infections.
Keyphrases
  • early onset
  • diffuse large b cell lymphoma
  • cystic fibrosis
  • hodgkin lymphoma
  • drug induced
  • antibiotic resistance genes
  • wastewater treatment